Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Medicine 52

Pharmaceutical Technology

NOVEMBER 30, 2022

Several other treatments, like Novo Nordisk’s CagriSema (semaglutide + cagrilintide), are expected to follow after showing encouraging Phase II data. Novo Nordisk is another company leading the charge in this field. However, Novo Nordisk’s anti-obesity therapeutics have had rough rollouts following their approvals.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

Several other treatments, like Novo Nordisk’s CagriSema (semaglutide + cagrilintide), are expected to follow after showing encouraging Phase II data. Novo Nordisk is another company leading the charge in this field. However, Novo Nordisk’s anti-obesity therapeutics have had rough rollouts following their approvals.

Medical 98

Medical Manufacturing Insurance Side effects 98